-+ 0.00%
-+ 0.00%
-+ 0.00%

Duopharma Biotech Settles Lawsuit Without Admission of Liability

PUBT·10/19/2026 10:25:04
Duopharma Biotech Settles Lawsuit Without Admission of Liability
  • Duopharma Biotech's litigation ended in an amicable settlement with no admission of liability.
  • The plaintiff discontinued the suit on October 19, 2026, without permission to refile; no costs were awarded.
  • The High Court canceled the trial scheduled to begin that day.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duopharma Biotech Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3716316) on October 19, 2026, and is solely responsible for the information contained therein.